Voting Rights Announcements | 9 November 2015 14:49
STRATEC Biomedical AG
09.11.2015 14:49
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
1. Ameriprise Financial, Inc.
Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us
pursuant to sec. 21 para. 1 WpHG on 2 November 2015, that on 29 October
2015 the share of voting rights in STRATEC Biomedical AG, Birkenfeld,
Germany, ISIN: DE000STRA555 went above the threshold of 5% and that the
percentage of voting rights on that day amounted to 5.0003% (592,361 voting
rights). Ameriprise Financial, Inc. has notified us that these voting
rights of 5.0003% (592,361 voting rights) are attributable to Ameriprise
Financial, Inc. pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection
with sent. 2 WpHG.
The voting rights were attributed to Ameriprise Financial, Inc. inter alia
from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or
more of the voting rights in STRATEC Biomedical AG.
2. Threadneedle Asset Management Holdings SARL
Threadneedle Asset Management Holdings SARL, Luxembourg, Luxembourg, has
notified us pursuant to sec. 21 para. 1 WpHG on 2 November 2015, that on 29
October 2015 the share of voting rights in STRATEC Biomedical AG,
Birkenfeld, Germany, ISIN: DE000STRA555 went above the threshold of 5% and
that the percentage of voting rights on that day amounted to 5.0003%
(592,361 voting rights). Threadneedle Asset Management Holdings SARL has
notified us that these voting rights of 5.0003% (592,361 voting rights) are
attributable to Threadneedle Asset Management Holdings SARL pursuant to
sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to Threadneedle Asset Management Holdings
SARL inter alia from Threadneedle Investment Funds ICVC, being a
shareholder holding 3% or more of the voting rights in STRATEC Biomedical
AG.
3. Threadneedle Holdings Limited
Threadneedle Holdings Limited, London, UK, has notified us pursuant to sec.
21 para. 1 WpHG on 2 November 2015, that on 29 October 2015 the share of
voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE000STRA555 went above the threshold of 5% and that the percentage of
voting rights on that day amounted to 5.0003% (592,361 voting rights).
Threadneedle Holdings Limited has notified us that these voting rights of
5.0003% (592,361 voting rights) are attributable to Threadneedle Holdings
Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent.
2 WpHG.
The voting rights were attributed to Threadneedle Holdings Limited inter
alia from Threadneedle Investment Funds ICVC, being a shareholder holding
3% or more of the voting rights in STRATEC Biomedical AG.
4. TAM UK Holdings Limited
TAM UK Holdings Limited, London, UK, has notified us pursuant to sec. 21
para. 1 WpHG on 2 November 2015, that on 29 October 2015 the share of
voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE000STRA555 went above the threshold of 5% and that the percentage of
voting rights on that day amounted to 5.0003% (592,361 voting rights). TAM
UK Holdings Limited has notified us that these voting rights of 5.0003%
(592,361 voting rights) are attributable to TAM UK Holdings Limited
pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to TAM UK Holdings Limited inter alia
from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or
more of the voting rights in STRATEC Biomedical AG.
5. Threadneedle Asset Management Holdings Limited
Threadneedle Asset Management Holdings Limited, London, UK, has notified us
pursuant to sec. 21 para. 1 WpHG on 2 November 2015, that on 29 October
2015 the share of voting rights in STRATEC Biomedical AG, Birkenfeld,
Germany, ISIN: DE000STRA555 went above the threshold of 5% and that the
percentage of voting rights on that day amounted to 5.0003% (592,361 voting
rights). Threadneedle Asset Management Holdings Limited has notified us
that these voting rights of 5.0003% (592,361 voting rights) are
attributable to Threadneedle Asset Management Holdings Limited pursuant to
sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to Threadneedle Asset Management Holdings
Limited inter alia from Threadneedle Investment Funds ICVC, being a
shareholder holding 3% or more of the voting rights in STRATEC Biomedical
AG.
6. TC Financing Limited
TC Financing Limited, London, UK, has notified us pursuant to sec. 21 para.
1 WpHG on 2 November 2015, that on 29 October 2015 the share of voting
rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE000STRA555
went above the threshold of 5% and that the percentage of voting rights on
that day amounted to 5.0003% (592,361 voting rights). TC Financing Limited
has notified us that these voting rights of 5.0003% (592,361 voting rights)
are attributable to TC Financing Limited pursuant to sec. 22 para. 1 sent.
1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to TC Financing Limited inter alia from
Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more
of the voting rights in STRATEC Biomedical AG.
7. Threadneedle Asset Management Limited
Threadneedle Asset Management Limited, London, UK, has notified us pursuant
to sec. 21 para. 1 WpHG on 2 November 2015, that on 29 October 2015 the
share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE000STRA555 went above the threshold of 5% and that the percentage of
voting rights on that day amounted to 5.0003% (592,361 voting rights).
Threadneedle Asset Management Limited has notified us that these voting
rights of 5.0003% (592,361 voting rights) are attributable to Threadneedle
Asset Management Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG.
The voting rights were attributed to Threadneedle Asset Management Limited
inter alia from Threadneedle Investment Funds ICVC, being a shareholder
holding 3% or more of the voting rights in STRATEC Biomedical AG.
8. Ameriprise International Holdings GmbH
Ameriprise International Holdings GmbH, Zug, Switzerland, has notified us
pursuant to sec. 21 para. 1 WpHG on 2 November 2015, that on 29 October
2015 the share of voting rights in STRATEC Biomedical AG, Birkenfeld,
Germany, ISIN: DE000STRA555 went above the threshold of 5% and that the
percentage of voting rights on that day amounted to 5.0003% (592,361 voting
rights). Ameriprise International Holdings GmbH has notified us that these
voting rights of 5.0003% (592,361 voting rights) are attributable to
Ameriprise International Holdings GmbH pursuant to sec. 22 para. 1 sent. 1
no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to Ameriprise International Holdings GmbH
inter alia from Threadneedle Investment Funds ICVC, being a shareholder
holding 3% or more of the voting rights in STRATEC Biomedical AG.
09.11.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com
End of Announcement DGAP News-Service
---------------------------------------------------------------------------